Sionna Therapeutics (SION) Shares Issued (2024 - 2025)
Sionna Therapeutics' (SION) quarterly Shares Issued came in at $200.1 million in Q4 2025, up 800264.0% year-on-year from N/an in Q4 2024, and up 200.0% quarter-over-quarter from -$200.1 million in Q3 2025.
Sionna Therapeutics (SION) Shares Issued (2024 - 2025) Analysis & Trends
Sionna Therapeutics has disclosed Shares Issued across 2 years of filings, most recently posting $200.1 million for Q4 2025.
- Shares Issued for Q4 2025 came in at $200.1 million, up 800264.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$318000.0 (down 100.16% YoY), and the FY2025 annual result was $202.1 million, up 143212.77% from the prior year.
- Shares Issued came in at $200.1 million for Q4 2025 at Sionna Therapeutics, up from -$200.1 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $202.4 million in Q1 2025 to a low of -$200.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 26,927.15 |
| 10 | Sionna Therapeutics | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 200.09 Mn |
| Dec 31, 2025 | 200.09 Mn |
| Sep 30, 2025 | -200.09 Mn |
| Sep 30, 2025 | -200.09 Mn |
| Jun 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Mar 31, 2025 | 202.39 Mn |
| Mar 31, 2025 | 202.39 Mn |
| Dec 31, 2024 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 116,000.00 |
| Sep 30, 2024 | 116,000.00 |